2015 Forward-looking Insight · Leapfrog Development of "Internet + Medical"
Comparative analysis of China-US healthcare systems, exploring internetization in medical services, wellness management and health insurance. Free report | 61 pages | 39 charts
Driven by new healthcare reforms and aging demographics, China's healthcare industry is entering a golden era. The total market size is projected to exceed 8 trillion RMB by 2020. Compared with the US model (private insurance + primary care gatekeeping), China suffers from severe resource mismatch – over 43.9% of outpatient visits are concentrated in tertiary hospitals. Hence, internet technologies become crucial to leapfrogging inefficiencies.
Government remains the core engine of medical reform. In 2015, the State Council repeatedly endorsed "Internet + Healthcare", unleashing policy dividends. To succeed, internet medical ventures must move in sync with public hospital reforms, drug supply guarantees, and tiered diagnosis guidelines. Policy navigation is essential for compliant innovation.
Online consultation platforms enable smart triage, pre-diagnosis guidance, and referral recommendation – directing mild and common conditions to grassroots facilities, thus alleviating overcrowded tertiary hospitals. The integration of family doctor contracts and digital health management reshapes the medical order.
"Three longs and one short": long queuing for registration, waiting and payment, while consultation is short. Tertiary hospitals congestion, low utilization of primary care, inefficient system.
Online triage / intelligent guidance → matched to primary or appropriate facility → remote follow-up & shared electronic health records → increase first-contact rate in community care.
Healthcare informatization in China is at a nascent stage with widespread data silos – only about 3% of hospitals achieve data interoperability. Internet companies start from non-core processes (appointments, payments, lab reports) and move toward core clinical data; meanwhile, private insurers accelerate data integration for cost control. Healthcare big data is the next blue ocean.
| Barriers | Innovative Players | Core Opportunities |
|---|---|---|
| Non-standard data, disconnected systems | Internet giants (Alibaba Health, WeChat, etc.) | Patient flow engagement, accumulate behavior + medical data to build health platforms |
| Uneven hospital IT development | Commercial health insurers | Cost-control driven data integration, inform actuarial innovation & value-based care |
| Limited structured clinical data | Tech firms & AI startups | Clinical decision support & chronic disease management using big data analytics |
Patient service information systems have less than 50% penetration. Internet firms are gradually shifting from peripheral apps to core data accumulation, accelerating health IT growth.
The "drug mark-up" model has long inflated drug prices. Reforms aim to remove drug mark-ups in public hospitals and establish centralized procurement platforms, reducing hospitals’ reliance on drug revenue. This directly unleashes the potential for e‑pharmacy. The future ecosystem will connect manufacturers, distributors, insurers and patients, forming a "cloud pharmacy".
Over 75% of China’s urban population is sub‑healthy, and chronic disease prevalence continues rising. The wellness management field has low entry barriers, spurring wearables, genetic testing, and disease intervention apps. The future will shift from pure monitoring to precision "whole-lifecycle management", spawning sub‑domains like sports nutrition, mental health, and chronic disease coaching.
Step counts, heart rate, simple metrics; insufficient linkage to disease prevention, weak user stickiness.
Integrating genomics, continuous physiological data, and AI coaching to deliver personalized chronic intervention, reducing dependency on hospital visits.
Commercial insurance evolves from a supplementary payer to an ecosystem integrator: connecting hospitals, pharmacies, online medical platforms, building closed loops of "diagnosis + medication + insurance + wellness management". Big data enables dynamic pricing and cost containment. Innovative products (e.g., behavior‑linked policies for chronic patients) drive cross‑industrial connectivity.
Population aged ≥65 reached 138 million (>10.1%). Average household size dropped below 3 persons, intensifying demand for long‑term care and tele‑medicine.
Hypertension 2‑week prevalence increased from 3.9% (1993) to 31.4% (2008); diabetes from 0.8% to 6.0%. This makes chronic care and health management an urgent necessity.
By 2020 China’s GDP is expected to reach 92 trillion RMB, with health services share approaching global average. Household healthcare spending rose to 6.2% of total consumption, service‑oriented demand dominates.
US EHR adoption exceeds 70% among physicians & hospitals, telehealth widely accepted. China: only 3% of hospitals have interoperable data, still at early clinical informatics stage. Internet‑first approach will accelerate catch‑up.
| Dimension | United States | China |
|---|---|---|
| Health IT Maturity | Stage III (regional health info exchange, widespread EHR) | Early Stage II, clinical data silos remain the norm |
| Digital Health Drivers | Private insurance + market coordination, high hospital IT base | Internet companies / insurers + policy mandates, government-led reform |
| Tiered Diagnosis Foundation | Mature primary care gatekeeping (family physicians) | Internet triage + policy pilots progressively building primary capacity |
| Healthcare Big Data | Standardized EHR, precision medicine foundation | Fragmented data; web giants consolidating patient-side data to fill gaps |
Drawing on US experience, China is poised for a leapfrog transformation via "Internet + Healthcare". The six major trends will reshape the industry landscape.
Policy, demand and technology converge. Core internetization paths include: digital tiered diagnosis, data‑driven precision operations, e‑pharmacy ecosystem reconstruction, innovative commercial health insurance models, and full‑cycle personal health management. By 2020, the industry scale is expected to surpass 8 trillion RMB, shifting the focus from "disease treatment" to "health promotion".